SARS-COV-2 reagent kit 1158701

solutionreagent mediumclinical

Serological tests for quantitative and qualitative detection of total antibodies against Spike RBD S1 protein or Nucleocapsid (NC) protein of SARS-CoV-2 IMMUNE RESPONSE ASSESSMENT by measuring both S1 and NC antibodies. FAST RESULTS Time to results about 10 minutes. HIGH THROUGHPUT CAPACITY with full traceability. -The quick solution for evaluating immunity status of patients -Ideal solution for screening of community and population -Applicable on most common clinical chemistry analyzers -High performance, ready-to-use reagents, long shelf life and onboard stability -Avoid interference due to Biotin and HAMA -Better precision and repeatability than rapid card tests -Very good correlation with PCR results -Environmental sustainable product from ISO 14001:2015 certified company THE IDEAL SOLUTION FOR -verifying immune response after vaccination -monitoring the spread of infection in population -identifying potential current infections and asymptomatic patients A total of 479 (105 positive and 374 negative) patients samples have been tested with the COVID-19 anti-S1 Total Ab and the COVID-19 anti-NC Total Ab kits and compared to the results of an automated commercial available method for detection of total antibodies to SARS-CoV-2.